H3K36me3 drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (14)
Papers in which this entity is mentioned.
- Advancing regulatory variant effect prediction with AlphaGenome. (2026)
- Nucleotide Transformer: building and evaluating robust foundation models for human genomics. (2025)
- Transcription start sites experience a high influx of heritable variants fueled by early development. (2025)
- Global impact of unproductive splicing on human gene expression. (2024)
- DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers. (2020)
- Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. (2020)
- Universal Patterns of Selection in Cancer and Somatic Tissues. (2017)
- Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. (2017)
- Orthotopic patient-derived xenografts of paediatric solid tumours. (2017)
- The Ensembl gene annotation system. (2016)
- ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. (2012)
- Identifying ChIP-seq enrichment using MACS. (2012)
- An integrated encyclopedia of DNA elements in the human genome. (2012)
- Functional consequences of developmentally regulated alternative splicing. (2011)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| h3k36me3 | drug | 33 | 103 |